NewsRx

Search our medical news database

University of California - San Francisco

Post-term pregnancies risk infant's life and health, UCSF studies show

Published in OBGYN and Reproduction Week, November 3rd, 2008

Infants born more than one week past their due dates have a higher risk of both impaired health and death, according to two new studies by authors from the University of California's San Francisco and Berkeley campuses.

The studies compared more than 2.5 million normal-weight births from healthy pregnancies of 37 to 42 weeks gestation, the range that is considered to be full-term. Findings appear in the October, 2008 issue of the American Journal of Obstetrics and Gynecology and also can be found online at www.ajog.org.

The two studies focused on different elements of the risk of progressing beyond 41 weeks of gestation, but held similar conclusions....

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of OBGYN and Reproduction Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook